An Annapolis firm focused on building medical devices to monitor heart disease has raised $1.5 million to help bring its first product to market.
Vixiar Medical Inc., a spinout of Johns Hopkins, is developing non-invasive devices and systems for monitoring cardiopulmonary diseases. Its seed round included investors from the U.S. Asia and Europe. Local investors include the Abell Foundation and Maryland Technology Development Corp. The company is based on technology licensed from Hopkins and invented by cardiologist Dr. Harry Silber.
{iframe}https://www.bizjournals.com/baltimore/news/2017/07/24/annapolis-medical-device-firm-raises-1-5-million.html?ana=e_ae_set1&s=article_du&ed=2017-07-24&u=DauP8f%2Bt62nzWUaJSWXfjw0aaeb639&t=1500924214&j=78594851{/iframe}